Who’s leading the R&D race, and what’s in store this season
Every medicine that reaches a patient has run a long race: from a crowded grid of thousands of candidates, through the circuit of clinical development, to the podium of a market launch. This report follows that race in full, drawing on Citeline’s Pharmaprojects and Trialtrove.
